Simultaneous delivery of multiple chemotherapeutic agents at specific tumor sites through engineerable nanovesicles (Equipment)
Principal Investigator
Prof. Sanjib Senapati
Objective
- in this proposal, a novel, biocompatible and inexpensive AOT based nano size vesicle for the co-delivery of Dox and Cur drugs has been proposed.
Description
- In this work, our starting hypothesis is that the simultaneous delivery of existing chemotherapeutic agents and a chemosensitizer to the cancer site could enhance the anticancer efficacy. In recent years, nano sized vesicles which are made up of nonionic amphiphilic molecules are widely used as a carrier in drug delivery applications due to their biocompatibility and easy membrane permeability. The AOT-based nanovesicles can simultaneously encapsulate both hydrophilic and hydrophobic drugs. This ability makes it a suitable candidate for combinatorial therapy.
Impact
- If successful, the proposed work will provide a novel approach to develop nanovesicles as a smart drug delivery to carry multiple cancer drugs to the specific tumour site.
Budget in Lakhs
100.00
Duration
3 Years

